Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal …

C Zoccali, F Mallamaci, M Adamczak… - Cardiovascular …, 2023 - academic.oup.com
Chronic kidney disease (CKD) is classified into five stages with kidney failure being the most
severe stage (stage G5). CKD conveys a high risk for coronary artery disease, heart failure …

Recognition and management of resistant hypertension

B Braam, SJ Taler, M Rahman, JA Fillaus… - Clinical journal of the …, 2017 - journals.lww.com
Despite improvements in hypertension awareness and treatment, 30%–60% of hypertensive
patients do not achieve BP targets and subsequently remain at risk for target organ damage …

Risk Factors of Chronic Kidney Disease Progression: Between Old and New Concepts

F Mallamaci, G Tripepi - Journal of Clinical Medicine, 2024 - mdpi.com
Chronic kidney disease (CKD) is a condition characterized by the gradual loss of kidney
function over time and it is a worldwide health issue. The estimated frequency of CKD is …

Loop diuretics in the treatment of hypertension

L Malha, SJ Mann - Current hypertension reports, 2016 - Springer
Loop diuretics are not recommended in current hypertension guidelines largely due to the
lack of outcome data. Nevertheless, they have been shown to lower blood pressure and to …

Efficacy and safety of renal denervation for hypertension in patients with chronic kidney disease: a meta-analysis

M Xia, T Liu, D Chen, Y Huang - International Journal of …, 2021 - Taylor & Francis
Background Renal denervation (RDN) is a new treatment for hypertension in patients with
chronic kidney disease (CKD), but its efficacy is still debated. This meta-analysis aimed to …

Mapping progress in reducing cardiovascular risk with kidney disease: managing volume overload

C Zoccali, F Mallamaci - Clinical Journal of the American Society …, 2018 - journals.lww.com
Volume overload (1) and its attendant complicationshypertension, left ventricular
hypertrophy, and heart failure-are often evident in patients with stage G3 CKD, and the …

[HTML][HTML] Hydration status according to impedance vectors and its association with clinical and biochemical outcomes and mortality in patients with chronic kidney …

PVM Alatriste, EC Ramírez, XA Carsi… - … : Organo oficial de la …, 2022 - dialnet.unirioja.es
Antecedentes: la evaluación del estado de hidratación y la composición corporal es
imprescindible para los pacientes con enfermedad renal crónica (ERC) en estadios …

Any grade of relative overhydration is associated with long-term mortality in patients with Stages 4 and 5 non-dialysis chronic kidney disease

A Vega, S Abad, N Macías, I Aragoncillo… - Clinical kidney …, 2018 - academic.oup.com
Background Overhydration (OH) is associated with mortality in chronic kidney disease
(CKD). A relative overhydration adjusted for extracellular water (OH/ECW) measured by …

Measuring fluid balance in end-stage renal disease with a wearable bioimpedance sensor

F Bremnes, CM Øien, J Kvaerness, EA Jaatun, SN Aas… - BMC nephrology, 2025 - Springer
Background Accurate assessment of fluid volume and hydration status is essential in many
disease states, including patients with chronic kidney disease. The aim of this study was to …

Current issues in the management and monitoring of hypertension in chronic kidney disease

PS Garimella, K Uhlig - Current opinion in nephrology and …, 2013 - journals.lww.com
Although we have effective tools to monitor and lower BP, we still need clinical outcome
studies to inform BP targets for specific age groups, types of CKD disease, and …